GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » Cyclically Adjusted Revenue per Share

CrystalGenomics Invites Co (XKRX:083790) Cyclically Adjusted Revenue per Share : ₩238.71 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CrystalGenomics Invites Co's adjusted revenue per share for the three months ended in Mar. 2024 was ₩9.250. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩238.71 for the trailing ten years ended in Mar. 2024.

During the past 12 months, CrystalGenomics Invites Co's average Cyclically Adjusted Revenue Growth Rate was -4.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of CrystalGenomics Invites Co was 12.30% per year. The lowest was -3.20% per year. And the median was 7.80% per year.

As of today (2024-06-10), CrystalGenomics Invites Co's current stock price is ₩2495.00. CrystalGenomics Invites Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩238.71. CrystalGenomics Invites Co's Cyclically Adjusted PS Ratio of today is 10.45.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CrystalGenomics Invites Co was 130.24. The lowest was 9.27. And the median was 58.60.


CrystalGenomics Invites Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for CrystalGenomics Invites Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co Cyclically Adjusted Revenue per Share Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 192.15 170.00 233.35 245.86 240.52

CrystalGenomics Invites Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 249.66 259.24 270.14 240.52 238.71

Competitive Comparison of CrystalGenomics Invites Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, CrystalGenomics Invites Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's Cyclically Adjusted PS Ratio falls into.



CrystalGenomics Invites Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CrystalGenomics Invites Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.25/118.8477*118.8477
=9.250

Current CPI (Mar. 2024) = 118.8477.

CrystalGenomics Invites Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 20.942 99.353 25.051
201409 24.190 99.608 28.862
201412 41.786 99.098 50.114
201503 49.514 99.720 59.011
201506 17.370 100.050 20.634
201509 57.240 100.110 67.954
201512 24.126 100.220 28.610
201603 93.334 100.560 110.308
201606 184.761 100.790 217.863
201609 88.777 101.460 103.991
201612 6.301 101.560 7.374
201703 78.319 102.850 90.501
201706 61.208 102.610 70.894
201709 85.166 103.490 97.804
201712 33.088 102.990 38.183
201803 19.479 104.100 22.239
201806 109.078 104.130 124.495
201809 17.508 105.650 19.695
201812 77.224 104.350 87.953
201903 18.034 104.490 20.512
201906 17.648 104.880 19.998
201909 17.841 105.200 20.156
201912 183.748 105.120 207.744
202003 73.185 105.540 82.413
202006 446.812 104.870 506.366
202009 368.109 106.200 411.948
202012 -976.114 105.765 -1,096.851
202103 97.344 107.357 107.763
202106 62.867 107.579 69.452
202109 200.925 108.759 219.563
202112 343.214 109.676 371.914
202203 119.034 111.806 126.531
202206 79.618 114.083 82.943
202209 73.060 114.831 75.615
202212 -142.528 115.200 -147.041
202303 26.446 116.550 26.967
202306 93.890 117.140 95.259
202309 84.709 119.111 84.522
202312 -179.509 118.848 -179.509
202403 9.250 118.848 9.250

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


CrystalGenomics Invites Co  (XKRX:083790) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CrystalGenomics Invites Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2495.00/238.71
=10.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CrystalGenomics Invites Co was 130.24. The lowest was 9.27. And the median was 58.60.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CrystalGenomics Invites Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines